Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Alpha Teknova, Inc. TKNO

Healthcare  —  Drug Manufacturers Specialty & Generic
9.33 0.04 0.43% as of 25 Sep
Market cap
$498.8M
P/E
0.0×
Cash Flow Champion (3y) Insider Buys (last 12m)
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Alpha Teknova, Inc. (TKNO) Business Profile

Updated before January 2025

Company Overview

Alpha Teknova, Inc. (TKNO) is a leading provider of critical reagents and solutions for the life sciences industry. Founded in 1996 and headquartered in Hollister, California, the company has established itself as a trusted partner for biotechnology and pharmaceutical companies, academic research institutions, and diagnostic companies. Teknova specializes in the production of high-quality, custom, and catalog products that are essential for research, development, and manufacturing processes in the life sciences sector.

The company was founded by Ted Davis, who envisioned a business that could meet the growing demand for high-quality reagents tailored to the specific needs of researchers and manufacturers. Over the years, Teknova has grown significantly, driven by its commitment to innovation, quality, and customer service. The company is led by a team of experienced executives, including CEO Stephen Gunstream, who brings extensive expertise in the life sciences and biotechnology industries. Under his leadership, Teknova has expanded its product offerings and strengthened its position in the market.

Core Business Segments

Teknova operates in several core business segments, offering a wide range of products and services that cater to the diverse needs of its customers. These segments include:

1. Custom Solutions

Teknova specializes in providing custom solutions tailored to the unique requirements of its clients. These include custom buffers, reagents, and media formulations that are critical for various applications in research, development, and manufacturing. The company’s ability to deliver high-quality, customized products quickly and efficiently sets it apart from competitors.

2. Catalog Products

In addition to custom solutions, Teknova offers a comprehensive catalog of ready-to-use products. These include:

  • Buffers and Reagents: Essential for molecular biology, cell culture, and other life sciences applications.
  • Agar Plates: Used for microbial culture and diagnostic testing.
  • Liquid Media: Designed for cell growth and maintenance in research and industrial settings.

3. GMP Manufacturing

Teknova provides Good Manufacturing Practice (GMP) services to support the production of clinical and commercial products. This includes the manufacture of reagents and solutions that meet stringent regulatory requirements, ensuring safety and efficacy for use in therapeutic and diagnostic applications.

4. Diagnostic and Therapeutic Applications

The company also supports the development and production of diagnostic and therapeutic products, offering specialized reagents and solutions that are critical for these applications. This includes products used in next-generation sequencing (NGS), cell and gene therapy, and other cutting-edge technologies.

Business Model

Teknova’s business model is centered around its ability to provide high-quality, customized solutions that meet the specific needs of its customers. The company integrates its products and services to deliver value across the entire life sciences ecosystem. Key aspects of its business model include:

  • Customization: Teknova’s ability to produce tailored solutions quickly and efficiently is a core strength. This allows the company to address the unique requirements of its customers, from small research labs to large pharmaceutical companies.
  • Quality and Compliance: The company maintains rigorous quality control processes and adheres to strict regulatory standards, ensuring that its products meet the highest levels of safety and efficacy.
  • Customer Focus: Teknova places a strong emphasis on building long-term relationships with its customers, providing exceptional service and support to help them achieve their goals.
  • Revenue Generation: The company generates revenue through the sale of custom and catalog products, as well as GMP manufacturing services. Its diverse product portfolio and customer base provide a stable and growing revenue stream.

Strategic Direction

Teknova is focused on driving growth and innovation in the life sciences industry. Key elements of its strategic direction include:

  • Expansion of Product Offerings: The company plans to continue expanding its catalog and custom product offerings to meet the evolving needs of its customers.
  • Investment in Technology: Teknova is investing in advanced manufacturing technologies and automation to improve efficiency and scalability.
  • Sustainability Goals: The company is committed to reducing its environmental impact by adopting sustainable practices in its operations and product development.
  • Global Expansion: Teknova aims to expand its presence in international markets, leveraging its expertise and reputation to capture new opportunities.
  • Focus on Emerging Applications: The company is actively exploring new product categories and applications, such as cell and gene therapy, to capitalize on emerging trends in the life sciences industry.

Competitive Landscape

Teknova operates in a highly competitive market, facing competition from both established players and emerging companies. Key competitors include:

  • Thermo Fisher Scientific: A global leader in life sciences products and services.
  • MilliporeSigma: Known for its comprehensive portfolio of reagents and solutions.
  • Lonza Group: Specializes in biopharmaceutical manufacturing and research products.
  • Smaller Niche Players: Teknova also competes with smaller companies that focus on specific product categories or applications.

Despite the competition, Teknova differentiates itself through its focus on customization, quality, and customer service, which have helped it build a loyal customer base.

Risk Factors

Like any business, Teknova faces several risks that could impact its operations and financial performance. Key risk factors include:

  • Market Dependence: The company’s revenue is heavily dependent on the life sciences industry, which is subject to fluctuations in funding and demand.
  • Supply Chain Disruptions: Teknova relies on a global supply chain for raw materials, making it vulnerable to disruptions caused by geopolitical events, natural disasters, or other factors.
  • Regulatory Challenges: The company operates in a highly regulated industry, and changes in regulations or compliance issues could affect its operations.
  • Competition: Intense competition from larger players and niche companies could impact Teknova’s market share and profitability.

Recent Developments

Teknova has made significant strides in recent years, including:

  • Product Innovations: The company has introduced new products and solutions to address emerging needs in the life sciences industry.
  • Operational Improvements: Investments in automation and advanced manufacturing technologies have improved efficiency and scalability.
  • Strategic Partnerships: Teknova has formed partnerships with leading companies and research institutions to drive innovation and expand its market reach.
  • Response to Global Events: The company has adapted to challenges posed by the COVID-19 pandemic, ensuring continuity of supply and support for its customers.

Investment Considerations

Investors considering Teknova should weigh the following strengths and risks:

Strengths

  • Strong reputation for quality and customization.
  • Diverse product portfolio and customer base.
  • Growth potential in emerging applications such as cell and gene therapy.
  • Commitment to innovation and sustainability.

Risks

  • Dependence on the life sciences industry and its funding cycles.
  • Vulnerability to supply chain disruptions and regulatory changes.
  • Intense competition from larger players and niche companies.

Conclusion

Alpha Teknova, Inc. is a dynamic and innovative company that plays a critical role in the life sciences industry. With its focus on customization, quality, and customer service, Teknova has established itself as a trusted partner for researchers and manufacturers worldwide. The company’s strategic investments in technology, sustainability, and global expansion position it for continued growth and success in the years ahead. While it faces challenges such as market dependence and competition, Teknova’s strengths and commitment to innovation make it a compelling choice for customers and investors alike.